The purpose of this observational study is to
evaluate if the level of a blood marker called presepsin can help
differentiate sepsis from systemic inflammatory response syndrome
(SIRS) in hospitalized patients with sepsis or SIRS. Patients will
be recruited exclusively from the critical care unit.